US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 116.950
  • +0.140+0.12%
Close Jul 23 16:00 ET
  • 116.950
  • 0.0000.00%
Post 17:03 ET
7.32BMarket Cap-24263P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Blueprint Medicines Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 1, 2024

Revenue(YoY)

103.46M

+79.71%
EPS(YoY)

-1.29

+40.99%
Analyst Rating

Buy

Jul 23, 2024

Blueprint Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 112.621M--
Aug 1, 20242024/Q2-- / 103.461M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
Oct 26, 20232023/Q356.566M / 50.652M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 112.621M--
Aug 1, 20242024/Q2-- / 103.461M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
Oct 26, 20232023/Q356.566M / 50.652M--

Unlock Free Earnings Estimates

Blueprint Medicines Earnings Reports

  • Blueprint Medicines | 10-Q: Quarterly report

    May 2 16:51 ET

  • Blueprint Medicines | 10-K: Annual report

    Feb 15 22:20 ET

  • Blueprint Medicines | 10-Q: Q3 2023 Earnings Report

    Oct 26, 2023 16:01 ET

  • Blueprint Medicines | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 23, 2024

    Buy

    • Buy

      76.92%

    • Hold

      15.39%

    • Sell

      7.69%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Cancer Research
    Cancer Research
    Intraday-0.75%